Geode Capital Management, LLC Synthetic Biologics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.9 - $2.9 $71,658 - $109,373	37,715 Added 3.34%	1,165,836 $248,000
Q1 2022 May 13, 2022	BUY	$2.3 - $4.3 $349,151 - $652,761	151,805 Added 15.55%	1,128,121 $321,000
Q3 2021 Nov 12, 2021	BUY	$4.3 - $5.8 $86,150 - $116,203	20,035 Added 2.1%	976,316 $448,000
Q2 2021 Aug 13, 2021	BUY	$4.6 - $7.2 $440,969 - $690,213	95,863 Added 11.14%	956,281 $576,000
Q1 2021 May 12, 2021	BUY	$5.0 - $11.7 $4.21 Million - $9.86 Million	842,785 Added 4779.59%	860,418 $586,000
Q3 2018 Nov 13, 2018	SELL	$20.4 - $80.5 $12.2 Million - $48.3 Million	-599,503 Reduced 97.14%	17,633 $45,000
Q2 2018 Aug 14, 2018	BUY	$73.5 - $129.5 $45.4 Million - $79.9 Million	617,136 New	617,136 $147,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.